B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Zstk 474

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Zstk 474, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gedatolisib
6 shared targets
voxtalisib
5 shared targets
sapanisertib
5 shared targets
duvelisib
4 shared targets
bimiralisib
6 shared targets
copanlisib
5 shared targets
pf
5 shared targets
vs
5 shared targets
gsk
3 shared targets
vistusertib
5 shared targets
Loading evidence profile...

This evidence profile for Zstk 474 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.